WVP
ACHV icon

Worth Venture Partners’s Achieve Life Sciences ACHV Stock Holding History

Worth Venture Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-718
Closed -$24K – 89
2019
Q3 		$24K Sell
718
-2,871
-80% -$113K 0.01% 89
2019
Q2 		$139K Sell
3,589
-2,594
-42% -$183K 0.08% 71
2019
Q1 		$399K Buy
6,183
+1,701
+38% +$68.7K 0.22% 52
2018
Q4 		$108K Buy
4,482
+2,882
+180% +$109K 0.08% 68
2018
Q3 		$101K Buy
+1,600
New +$101K 0.08% 99

Other funds holding ACHV

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Searle & Co Greenwich, Connecticut $445M AUM 41.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Worth Venture Partners's ACHV Position: Q4 2019 in Review

Worth Venture Partners sold out of Achieve Life Sciences (ACHV) in Q4 2019, closing a stake of 718 shares — an estimated $24K sold.

Worth Venture Partners first reported a position in ACHV in Q3 2018 and held it in 5 quarters. The position peaked at $399K in Q1 2019. 17 funds tracked by Wall St. Rank hold ACHV as of Q4 2019.

  • Worth Venture Partners reported no remaining Achieve Life Sciences position as of Q4 2019 after selling out during the quarter.
  • Worth Venture Partners sold 718 Achieve Life Sciences shares in Q4 2019, an estimated $24K.
  • Worth Venture Partners first reported a position in Achieve Life Sciences in Q3 2018 and held it in 5 quarters.
  • Worth Venture Partners's Achieve Life Sciences position peaked at $399K in Q1 2019.
  • 17 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2019.

Based on Worth Venture Partners's 13F filing for Q4 2019, filed 14 Feb 2020.